Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001088020-13-000005)

Filing Details

Accession Number:: 0001088020-13-000005
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-02-05 16:56:36
Reporting Period:: 2013-02-01

Filing Date:: 2013-02-05
Accepted Time:: 2013-02-05 16:56:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
911216	Palatin Technologies Inc	PTN	Pharmaceutical Preparations (2834)	954078884

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1304773	W Alan Dunton	Palatin Technologies, Inc. 4B Cedar Brook Drive Cranbury NJ 08512		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-02-01	1,000	$0.58	5,520	No	4	P	Indirect	By SEP IRA and Danerius LLC
Common Stock	Acquisiton	2013-02-01	1,000	$0.59	6,520	No	4	P	Indirect	By SEP IRA and Danerius LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By SEP IRA and Danerius LLC
No	4	P	Indirect	By SEP IRA and Danerius LLC

Footnotes

Of the 6,520 shares reported, 2,000 are owned by Dr. Dunton's SEP IRA and 4,520 are owned by Danerius LLC. Dr. Dunton is the majority owner and president of Danerius LLC, a consulting company for the pharmaceutical industry.